secondary efficacy endpoint

Related by string. secondary efficacy endpoints * Secon dary . SECONDARY . Secondary : Secondary Offering . Secondary School . Secondary Schools . secondary / Efficacy . EFFICACY : primary efficacy endpoint . antimicrobial efficacy . preclinical efficacy / Endpoints . EndPoint . Endpoint : Secondary endpoints include . video conferencing endpoints . Secondary endpoints included * *

Related by context. Frequent words. (Click for all words.) 73 composite endpoint 73 secondary endpoint 69 secondary efficacy endpoints 69 Secondary endpoints 68 prespecified 67 primary efficacy endpoint 67 Secondary endpoints included 67 primary endpoint 66 achieved statistical significance 65 clinical endpoints 65 cytogenetic response 65 Secondary endpoints include 65 virologic response 64 systemic embolism 64 secondary endpoints 64 annualized relapse 64 noninferiority 63 infarct size 63 Thrombolysis 63 irbesartan 63 TRITON TIMI 63 placebo controlled clinical 63 tumor resection 62 tolvaptan 62 gout flares 62 TAXUS Stent 62 COPD exacerbations 62 sustained virologic response 61 myocardial infarction stroke 61 sensitivity specificity 61 mg kg dose 61 serum phosphorus 61 active comparator 61 RECIST criteria 61 cardiovascular morbidity 61 creatinine clearance 61 pharmacodynamic effects 61 ADAS cog 61 evaluable 61 tolerated dose MTD 61 DOXIL 61 peginterferon alfa 2a 61 PANSS 60 EBRT 60 virologic failure 60 androgen deprivation 60 coronary revascularization 60 #mg dose [003] 60 FOLFIRI 60 neoadjuvant 60 primary efficacy endpoints 60 platelet inhibition 60 fibrinolysis 60 primary endpoints 60 tipranavir 60 stent implantation 60 glomerular filtration rate 60 thromboembolic events 60 subgroup analyzes 60 Fidaxomicin 60 cardiovascular hospitalization 60 nab paclitaxel 59 univariate 59 AZOR 59 inflammatory lesions 59 HSCT 59 COPAXONE R 59 target vessel revascularization 59 nephrectomy 59 preoperatively 59 T2DM 59 vasospasm 59 carotid intima media 59 azacitidine 59 cystectomy 59 Navelbine 59 PROMACTA 59 HbA1c levels 59 SABCS 59 serum concentrations 59 patients evaluable 59 comorbid conditions 59 cerebrovascular events 59 HbA 1c 59 ADHD RS 58 peginterferon 58 anticoagulant therapy 58 nonresponders 58 evaluable patients 58 mcg kg 58 chemoradiotherapy 58 fondaparinux 58 Solid Tumors 58 Lenalidomide 58 alvimopan 58 DAS# [002] 58 Azedra 58 estimated glomerular filtration 58 limiting toxicity 58 ALLHAT 58 Cmax

Back to home page